Literature DB >> 18060181

Biology of metalloproteinases.

Cornelia Amălinei1, Irina Draga Căruntu, Raluca Anca Bălan.   

Abstract

Matrix metalloproteinases (MMPs) occupy a central role in embryogenesis and in normal physiological conditions, such as proliferation, cell motility, remodeling, wound healing, angiogenesis, and key reproductive events. MMPs form a multigenic family of proteolytic, zinc-dependent enzymes, with 26 members described until present, displaying multidomain structures and substrate specificities. MMPs are involved in both the turnover and degradation of extracellular matrix (ECM) proteins and in the processing, activation, or deactivation of a variety of soluble factors. They are regulated at the level of transcription, activation of the precursor zymogens, and inhibition mainly by tissue inhibitors of metalloproteinases (TIMPs). Any loss in activity control may result in various diseases. This review provides an update of biological functions of MMPs, facilitating the understanding of the complex pathogenic mechanisms of medical conditions characterized by imbalance between MMP and TIMP expression. The design of potent specific inhibitors for MMPs represents a scientific challenge for the development of new therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18060181

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  35 in total

Review 1.  Role of various proteases in cardiac remodeling and progression of heart failure.

Authors:  Alison L Müller; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 2.  Matrix Metalloproteinases (MMPs) in Liver Diseases.

Authors:  Adnan Naim; Qiuwei Pan; Mirza S Baig
Journal:  J Clin Exp Hepatol       Date:  2017-10-03

3.  Pathological and molecular analyses of atherosclerotic lesions in ApoE-knockout mice.

Authors:  Masa-Aki Shibata; Eiko Shibata; Kentaro Maemura; Yoichi Kondo; Mariko Harada-Shiba
Journal:  Med Mol Morphol       Date:  2017-02-28       Impact factor: 2.309

4.  Effects of hydroxysafflor yellow A on proliferation and collagen synthesis of rat vascular adventitial fibroblasts induced by angiotensin II.

Authors:  Wendan Yuan; Dongxia Yang; Xuhong Sun; Wei Liu; Liang Wang; Xiaoyan Li; Xuejing Man; Qiang Fu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

5.  Balancing zinc deficiency leads to an improved healing of colon anastomosis in rats.

Authors:  Jochen Grommes; Marcel Binnebösel; Christian D Klink; Klaus Thilo von Trotha; Rafael Rosch; Alexander P Oettinger; Ines Lindlar; Carsten J Krones
Journal:  Int J Colorectal Dis       Date:  2010-10-16       Impact factor: 2.571

6.  An in vitro-in vivo model of epithelial mesenchymal transition in triple negative breast cancer.

Authors:  Yubo Zhai; Julia Santucci-Pereira; Ricardo Lopez de Cicco; Irma H Russo; Jose Russo
Journal:  Drug Discov Today Dis Mech       Date:  2012

7.  Regulation of matrix metalloproteinase-2 and -9 during healing of dermal wounds after incision using radiofrequency energy in neonatal and adult rats.

Authors:  M Asimakidou; L Oikonomou; A Filipopoulos; G Tsikopoulos; A S Petropoulos
Journal:  Hippokratia       Date:  2017 Apr-Jun       Impact factor: 0.471

Review 8.  Multiscale models of angiogenesis.

Authors:  Amina A Qutub; Feilim Mac Gabhann; Emmanouil D Karagiannis; Prakash Vempati; Aleksander S Popel
Journal:  IEEE Eng Med Biol Mag       Date:  2009 Mar-Apr

9.  Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior.

Authors:  B J Grindel; J R Martinez; C L Pennington; M Muldoon; J Stave; L W Chung; M C Farach-Carson
Journal:  Matrix Biol       Date:  2014-05-14       Impact factor: 11.583

10.  Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus.

Authors:  Lucia Saucedo; Isabel B Pfister; Souska Zandi; Christin Gerhardt; Justus G Garweg
Journal:  Mediators Inflamm       Date:  2021-06-25       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.